Myomo Inc. (MYO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Myomo Inc. (MYO:NYSE), powered by AI.

Current Price
$1.53
P/E Ratio
-4.1
Market Cap
64M
Sector
Healthcare
What is the Myomo Inc. stock price forecast?

Myomo Inc. is currently trading at $1.53. View real-time AI analysis on Alpha Lenz.

What is Myomo Inc. insider trading activity?

View the latest insider trading data for Myomo Inc. on Alpha Lenz.

What is Myomo Inc.'s P/E ratio?

Myomo Inc.'s P/E ratio is -4.1.

Myomo Inc.

NYSE · MYO
$1.53+0.18(+13.33%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Myomo Inc.'s future dividend policy...
Alpha Chat Insight

Myomo Inc. trades at a P/E of -4.1 (undervalued) with modest ROE of -86.2%. 3Y revenue CAGR of 38.1% highlights clear growth momentum.

Ask for details

Company Overview

Myomo Inc. is a pioneering company in the field of medical robotics, specializing in the development and production of powered brace systems, specifically for upper-extremity mobility enhancement. These orthotic devices, branded under the name MyoPro, are designed to assist individuals dealing with neuromuscular malfunctions such as those caused by stroke, brachial plexus injury, or other neurological conditions. The primary function of MyoPro is to help users restore functionality and independence in their arms through advanced sensor technology that detects and amplifies the user's own muscle signals. Operating at the intersection of healthcare and technology, Myomo Inc. serves a vital role in the rehabilitation industry, transforming the lives of patients who previously had limited options for recovery. By providing a non-invasive solution to regain strength and mobility, the company's products are significant in addressing a growing need within the healthcare market. Myomo's innovative approach to patient care positions it as an influential player in the medical device sector, contributing to advancements in prosthetics and orthotics.

CEOMr. Paul R. Gudonis
SectorHealthcare
IndustryMedical Devices
Employees184

Company Statistics

FY 2025

Profile

$64.04MMarket Cap
$40.93MRevenue
0.00Shares Out
184Employees

Margins

65.70%Gross
-30.35%EBITDA
-35.19%Operating
-36.82%Pre-Tax
-38.05%Net

Valuation

-4.11P/E
5.62P/B
1.56EV/Sales
-5.58EV/EBITDA
-3.59P/FCF

Growth (CAGR)

38.05%Rev 3Yr
40.10%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-38.51%ROA
-86.24%ROE
-36.15%ROIC

Financial Health

$14.13MCash & Cash Equivalents
$13.10MNet Debt
238.81%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Myomo Inc. (ticker: MYO) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 184 employees. Market cap is $64M.

The current price is $1.53 with a P/E ratio of -4.11x and P/B of 5.62x.

ROE is -86.24% and operating margin is -35.19%. Annual revenue is $41M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Myomo Inc. (MYO) Stock Forecast 2026 $1.53 — Price, Financials & Analyst Targets | Alpha Lenz